Foster CS - Search Results

1

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

Mikropoulos C, Selkirk CGH, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, Jensen T, Osther PJ, van Asperen CJ, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Hart R, Glover W, Lam J, Taylor L, Salinas M, Feliubadaló L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Cook J, Rosario DJ, Buys SS, Conner T, Domchek S, Powers J, Ausems MG, Teixeira MR, Maia S, Izatt L, Schmutzler R, Rhiem K, Foulkes WD, Boshari T, Davidson R, Ruijs M, Helderman-van den Enden AT, Andrews L, Walker L, Snape K, Henderson A, Jobson I, Lindeman GJ, Liljegren A, Harris M, Adank MA, Kirk J, Taylor A, Susman R, Chen-Shtoyerman R, Pachter N, Spigelman A, Side L, Zgajnar J, Mora J, Brewer C, Gadea N, Brady AF, Gallagher D, van Os T, Donaldson A, Stefansdottir V, Barwell J, James PA, Murphy D, Friedman E, Nicolai N, Greenhalgh L, Obeid E, Murthy V, Copakova L, McGrath J, Teo SH, Strom S, Kast K, Leongamornlert DA, Chamberlain A, Pope J, Newlin AC, Aaronson N, Ardern-Jones A, Bangma C, Castro E, Dearnaley D, Eyfjord J, Falconer A, Foster CS, Gronberg H, Hamdy FC, Johannsson O, … See abstract for full author list ➔ Mikropoulos C, et al. Among authors: foster cs. Br J Cancer. 2018 Jan;118(2):266-276. doi: 10.1038/bjc.2017.429. Epub 2018 Jan 4. Br J Cancer. 2018. PMID: 29301143 Free PMC article.

2

Altered phosphorylation status, phospholipid metabolism and gluconeogenesis in the host liver of rats with prostate cancer: a 31P magnetic resonance spectroscopy study.

Dagnelie PC, Bell JD, Williams SC, Bates TE, Abel PD, Foster CS. Dagnelie PC, et al. Among authors: foster cs. Br J Cancer. 1993 Jun;67(6):1303-9. doi: 10.1038/bjc.1993.242. Br J Cancer. 1993. PMID: 8512815 Free PMC article.

3

Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells.

Ke Y, Beesley C, Smith P, Barraclough R, Rudland P, Foster CS. Ke Y, et al. Among authors: foster cs. Br J Cancer. 1998;77(2):287-96. doi: 10.1038/bjc.1998.45. Br J Cancer. 1998. PMID: 9461000 Free PMC article.

4

Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort.

Foster C, Evans DG, Eeles R, Eccles D, Ashley S, Brooks L, Davidson R, Mackay J, Morrison PJ, Watson M. Foster C, et al. Br J Cancer. 2002 Apr 22;86(8):1209-16. doi: 10.1038/sj.bjc.6600253. Br J Cancer. 2002. PMID: 11953874 Free PMC article.

5

Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching.

Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M. Hallowell N, et al. Genet Test. 2002 Summer;6(2):79-87. doi: 10.1089/10906570260199320. Genet Test. 2002. PMID: 12215246

6

Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information.

Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M. Hallowell N, et al. J Med Ethics. 2003 Apr;29(2):74-9; discussion 80-3. doi: 10.1136/jme.29.2.74. J Med Ethics. 2003. PMID: 12672886 Free PMC article.

7

ATM protein overexpression in prostate tumors: possible role in telomere maintenance.

Angèle S, Falconer A, Foster CS, Taniere P, Eeles RA, Hall J. Angèle S, et al. Among authors: foster cs. Am J Clin Pathol. 2004 Feb;121(2):231-6. doi: 10.1309/JTKG-GGKU-RFX3-XMGT. Am J Clin Pathol. 2004. PMID: 14983937

8

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.

Foster C, Evans DG, Eeles R, Eccles D, Ashley S, Brooks L, Cole T, Cook J, Davidson R, Gregory H, Mackay J, Morrison PJ, Watson M. Foster C, et al. Genet Test. 2004 Spring;8(1):23-9. doi: 10.1089/109065704323016003. Genet Test. 2004. PMID: 15140371

9

Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.

Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M. Hallowell N, et al. Soc Sci Med. 2004 Aug;59(3):553-65. doi: 10.1016/j.socscimed.2003.11.025. Soc Sci Med. 2004. PMID: 15144764

10

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome.

Foster CS, Falconer A, Dodson AR, Norman AR, Dennis N, Fletcher A, Southgate C, Dowe A, Dearnaley D, Jhavar S, Eeles R, Feber A, Cooper CS. Foster CS, et al. Oncogene. 2004 Aug 5;23(35):5871-9. doi: 10.1038/sj.onc.1207800. Oncogene. 2004. PMID: 15184867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,039 results

Search Page

Filters